Latest Breaking News On - Sorrento therapeutics inc nasdaq - Page 2 : comparemela.com

SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) Sorrento Therapeutics, Inc (Nasdaq: SRNE, “Sorrento”), a commercial and clinical-stage biopharmaceutical.

Henry jiTammy reillySorrento therapeutics inc nasdaqHealthcare businesswomen association rising starSemnur pharmaceuticals incUniversity of delawarePartner of real life productsExchange commissionSorrento therapeutics incXdx incPivotal trialc le ar programScilex pharmaceuticals incCaredx incRoche laboratoriesChief executive officerManaging partner